Uncover neurological complexity with pathway-level confidence

Neurological disease complexity extends far beyond what a set of established biomarkers can capture. Now, you can explore a new, comprehensive solution.

When used together in one study, Olink™ Target 48 Neurodegeneration and Olink™ can analyze 1,000+ protein biomarkers spanning established neurodegenerative markers and broader disease biology.

Anchor your discoveries in what is known. Reveal what is not.

Contact us to access this comprehensive solution that combines established neurological biomarkers with broad pathway coverage to help you uncover the biology driving disease onset, progression, heterogeneity and treatment response.